Advertisement
Advertisement

UTHR

UTHR logo

United Therapeutics Corp

280.10
USD
-1.06
-0.38%
Apr 14, 13:47 UTC -4
Open

United Therapeutics Corp Profile

About

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.

Info & Links

CEO

Martine Rothblatt

Headquarters

1000 SPRING ST
SILVER SPRING, MD 20910, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.unither.com

Auditor

Ernst & Young LLP

Share holders

26

Employees

1,305

United Therapeutics Corp Statistics

Valuation Measures

Market Capitalization2

12.58B

Enterprise Value

11.18B

Enterprise Value/EBITDA(ttm)

7.71

Price to Earnings Ratio(ttm)

16.13

Price to Sales(ttm)

5.95

Price to Book(mrq)

2.69

Price to Cash(ytd)

16.63

Profitability

Gross Margin(ttm)

89.24%

Operating Margin(ttm)

40.31%

Profit Margin(ttm)

41.59%

Return on Equity(ttm)

19.22%

Return on Invested Capital(ttm)

20.08%

Return on Assets(ttm)

16.15%

Income Statement

Revenue(ttm)

2.88B

Revenue Per Share(ttm)

64.07

Gross Profit(ttm)

2.57B

EBITDA(ttm)3

1.45B

Net Income Available to Common(ttm)

1.20B

Diluted EPS(ttm)

22.77

Share Statistics

Beta (5Y Monthly)

0.57

52-Week Change

20.43%

S&P 500 52-Week Change

6.55%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

44.91M

Dividend Yield

0.00%

Float4

39.33M

% Held by Insiders

11.90%

% Held by Institutions

94.08%

Balance Sheet

Total Cash(mrq)

3.27B

Total Cash Per Share(mrq)

72.74

Total Debt(mrq)

300.00M

Total Debt/Equity(mrq)

4.66%

Current Ratio(mrq)

5.25%

Quick Ratio(mrq)

4.41%

Book Value Per Share(mrq)

143.74

Cash Flow

Operating Cash Flow Per Share(ytd)

27.36

Free Cash Flow(ytd)

1.08B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement